Skip to main content
. 2014 Feb 5;16(1):R43. doi: 10.1186/ar4472

Figure 1.

Figure 1

Schematic of the study protocol. The 141 patients treated with prophylaxis trimethoprim/sulfamethoxazole (TMP/SMX (+)) were excluded from the analysis, and the 561 patients who did not receive prophylaxis (TMP/SMX (-)) were analyzed to reveal risk factors for Pneumocystis pneumonia (PCP).